Immunodeficiencies

08.08.2023

Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine


Source: Nutrients Authors: van Steenwijk H, Bast, A and de Boer A.

Beta-glucans derived from mushrooms are bioactive long-chain polysaccharide compounds, insoluble in water and with immunomodulatory properties. Knowledge of the action and functions of beta-glucans, which have been used in traditional medicine for centuries, is developing thanks to modern immunological and biotechnological methods.

Kategoria: General
Napisał: admin

Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine

This review has highlighted the potential application of fungal beta-glucans—immunomodulators that have been used in traditional Chinese medicine for centuries—in nutrition and medicine. From this review, it can be concluded that fungal glucans may play a promising role within both perspectives, and that there are possibilities to give traditional medicine an immunological application in both medicinal products and foods. Depending on the dosage, formulation, efficacy, safety profile, and route of administration, the immunomodulating effects that can be expected from fungal beta-glucans can either be considered a pharmaceutical effect (treating or curing a disease) or as a health effect originating from foods, focusing on the prevention of negative health effects.

In Europe, claims on health benefits are strictly regulated, with EFSA reviewing the scientific evidence that supports putative statements about health effects. As shown in this paper, all applications for putative health claims related to stimulation of the immune system and defense against pathogenic microorganisms have so far been rejected. Since EFSA has only approved immune claims for six vitamins and four essential trace elements, it can only be speculated that the temptation to add these ingredients to products is growing, rather than stimulating research into innovative foods. Comparing the evidence base of the putative health effects of fungal beta-glucan supplements with the guidance documents on immune support health claims, but even more importantly, the guidance documents on substantiating immune stimulation and pathogen defense by food products, it is shown that fungal glucans could play a role in supporting and maintaining health and, thus, can be seen as a good health-promoting substance from food—which could mean that this effect may also be claimed if approved.

In addition to these developments related to food uses of beta-glucan-containing supplements, beta-glucans could also hold a novel position in Western medicine, as the concept of trained immunity is relatively new and has not been investigated to a larger extent. The new insights and developments in trained immunity may lead to the possible application of fungal beta-glucans as NSIs in Western medicine. Due to the experience from Asian medicine and the relatively favorable safety profile, lentinan (i.v.) could potentially be a suitable fungal glucan within this new field of immunity. However, additional (preclinical) safety studies must first be performed to be eligible as a medicine in Europe. Imprime PGG, which is currently going through the stages of drug development, is another fungal beta-glucan worth investigating. Finally, given the different ways to purify and process beta-glucans, one of the biggest challenges remains the standardization and proper characterization of the active compounds themselves. However, with the help of modern immunological and biotechnological methods, increasing insights are gained into immunomodulating fungal beta-glucans, with potential applications both in foods and pharmaceutical products.

Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine Nutrients. 2021 Apr; 13(4): 1333. Published online 2021 Apr 17. doi: 10.3390/nu13041333

Secondary Immunodeficiencies

Otherwise known as acquired immunodeficiencies, they are much more common than primary immunodeficiencies. Secondary immunodeficiencies most often occur in diseases such as diabetes, sickle cell anaemia, rubella, leukaemia, chicken pox and various bacterial infections. The cause of secondary immunodeficiency can be malnutrition, surgery, burns or organ transplants and the administration of immunosuppressive drugs. Other causes can be diseases of the haematopoietic system, as well as autoimmune diseases. It can also be caused by HIV (Human Immunodeficieny Virus). AIDS, a disease caused by HIV, is also referred to as Acquired Immunodeficiency Syndrome. The result of HIV infection is a decrease in the number of lymphocyte-T cells, which makes the body more susceptible to diseases which, with normal immunity, pose no threat, but which can be fatal for HIV-positive people. Patients very often have atypical pneumonias, fungal infections, tumours and defects in the nervous system that eventually lead to death. Secondary immunodeficiencies are acquired and most often caused by iatrogenic disorders. The use of various immunosuppressive drugs, anti-cancer drugs or certain antibiotics further reduces immunity.

A number of situations in which immune disorders/deficiencies occur are summarised below.

Immune disorder of the elderly

Related to cellular immunity

  •   Gradual decline in the number of T lymphocytes after the age of 70
  •   An increase in the number of CD4 lymphocytes and a decrease in the number of CD8 lymphocytes
  •   Residual thymus function
  •   Increase in CD45RO expression, decrease in CD45RA expression
  •   Decrease in the expression of IL-2, IL-4 and INF-γ
  •   Weakening of the proliferative response of lymphocytes after stimulation with PHA and ConA
  •   Reducing the frequency of positive DTH reactions and weakening their intensity

Related to humoral immunity

  •   Decrease in IgM, IgE and IgD levels, increase in IgG levels
  •   Decrease in the titer of natural antibodies
  •   Increased titer of autoantibodies and anti-idiotypic antibodies
  •   Decrease in the number of CD5(-) B cells and increase in CD5(+) B cells after the age of 70
  •   Increased synthesis of IL-4, IL-5, IL-6, increased INF-γ activity

Immune disorders in renal failure

  •   Prolonged tolerance to allogeneic transplant
  •   Increased susceptibility to infections
  •   Increased cases of neoplasia
  •   Incorrect reaction to vaccines against viral infections (flu, hepatitis)

Immune disorders in uremia

  •   Chronic protein and calorie deficiency (insufficient supply, absorption disorders, excessive loss)
  •   Deficiencies of Zn, vitamins B6 and E
  •   Iron overload (ferritin over 500 mcg/l)
  •   Low- and high-molecular-weight uremic toxins
  •   Chronic dialysis therapy

Immune disfunction after surgery

  •   Occurrence of cutaneous anergy
  •   Decrease in IgG and IgM (preoperatively) against bacterial endotoxins
  •   A large decrease (>50%) in the number of lymphocytes on the 1st day after the procedure
  •   Increased neutrophil activity on the 1st - 2nd day
  •   Decrease (20-30%) of activated monocytes
  •   Increased IL-6 concentration

Drug-induced immune disorders

          After treatment with cytostatics

  •      Late neutropenia 35 – 45 days (irreversible damage to the myeloid stem cell)
  •      Early neutropenia 7 – 14 days (reversible damage to the myeloid stem cell)

          With other drugs - the drug (hapten) triggers abnormal destruction of granulocytes

          After long-term use of glucocorticosteroids - inhibition of granulocyte function

Effect of glucocorticosteroids

  •   Apoptosis of lymphocytes activated by allo- and autoantigens
  •   Reducing the expression of MCH antigens and adhesion molecules on cell surfaces
  •   Inhibition of nitric oxide synthase induction in macrophages
  •   Impaired function of cytotoxic lymphocytes and NK cells
  •   Inhibition of monocyte and macrophage functions

Infections complicating immunosuppressive treatment

  •   Cytomegalovirus (CMV) infection - in 80% of the population in youth it is asymptomatic, symptoms occur with reduced immunity
  •   Acute varicella zoster virus (VZV) infection
  •   Acute herpes virus infection (Herpes Simplex Virus – HSV)
  •   Tuberculosis and mycobacterioses
  •   Fungal infections (candida, cryptococcus, aspergillus)
  •   Pneumocystis pneumonia or PCP is a fungal infection

Stress and Immunity

Experimental studies on animals under stress show a decrease in cellular response indexes.

  •   Decrease in the number of lymphocytes
  •   Quantitative disorders of subpopulations
  •   Decrease in NK cell activity
  •   Decrease in the proliferative response to the antigen
  •   Phagocytosis disorders

Chronic stress → hypothalamus → pituitary gland → sympathetic system → ACTH, catecholamines, opioids → decreased IL2 production


Immune Disorders due to Ionising Radiation

  •   Total body irradiation = Total Lymphoid Irradiation
  •   The greatest excitability of dividing cells, e.g. lymphocytes stimulated by alloantigen
  •   Th lymphocytes more sensitive than Ts lymphocytes
  •   Macrophages and NK cells relatively resistant to irradiation

Immune disorders and certain cancers

The immune system performs immunological surveillance that prevents cancer by early detection and destruction of atypical cells. Immunosuppression and impaired immunity may lead to viral infections, which in turn may contribute to the development of a number of cancer diseases:

  •       Non-Hodgkin lymphomas (Epstein-Barr Virus – EBV)
  •       Kaposi sarcoma (human immunodeficiency virus – HIV)
  •       Skin cancer and rectal cancer (human papilloma virus – HPV)
  •       Primary liver cancer (hepatitis B virus – HBV)

Humoral Immune Disorders in the Course of Cancer

  •   Cytokines (mainly TGF-beta transforming growth factor) secreted by cancer cells (oat cell carcinoma, mesothelioma, Hodgkin's disease)
  •   Prostaglandins (mainly PGE2) secreted by macrophages (head and neck cancer)
  •   Gangliosides produced, i.a., by macrophages, erythrocytes, liver cells

Cellular Immune Disorders in the Course of Cancer

General:

  •   Reduction in the number of lymphocytes
  •   Decrease in the population of CD4 lymphocytes
  •   Decrease or reversal of CD4/CD8 ratio
  •   Weakened NK cells activity

Local (Cancer region, regional lymph nodes):

  •   Reduction in the number and dysfunction of mononuclear cells

Immune Disorders in the Course of Famine Disease

Fortunately, in our country and in Europe, hunger disease practically does not occur spontaneously. It may manifest itself in the course of other severe and long-term diseases, including: in the course of cancer, tuberculosis, pneumonia, severe diarrhea. Hunger disease is typical of war-affected regions and sub-Saharan Africa. In Europe in the 20th century, there were regions affected by famine, e.g. the great famine in Ukraine in 1932 - 1933, and famine in Nazi concentration camps or in the Nazi ghettos for Jews. In the course of starvation disease, a number of body disorders occur, including those in the immune system.

  •   Impaired cellular response
  •   Impaired phagocytosis
  •   Impaired production of cytokines, antibodies and complement system proteins
  •   Atrophy of the thymus and thymus-dependent lymph node zones

Other Secondary Immune Disorders

  •   In the course of infection (HIV, HTLV1 (Human T-cell Leukemia Virus), measles virus, tuberculosis
  •   Nutritional deficiencies (zinc, iron, vitamins A, E, B, folic acid)
  •       Endocrinopathy (hyperthyroidism, Cushing's disease, diabetes, hyperparathyroidism)
  •   Conditions after injuries, after extensive burns, deep hypothermia
  •   Protein loss (exudative enteropathies, nephrotic syndrome)
  •   Alcoholism, drug addiction

Structure of the Immune System

The immune system is a very complex structure consisting of cells, tissues and organs that work together to protect (defend) our body against "foreign" invaders . . .

How the Immune System Works?

It is one of nature's most fascinating inventions. It easily protects us against billions of bacteria, viruses and pathogens. We don't realize that the immune system . . .

Immunodeficiencies

Immunodeficiencies are disorders of the immune system that are characterized by a reduced or lack of ability to . . .

Maintain Healthy Immune System

If we are not dealing with an immune system disease, it is usually enough to use a few simple . . .

News

The European Medicines Agency (EMA) has approved gene therapy for the treatment of severe combined immunodeficiency due to adesine deaminase deficiency (ADA-SCID), which is the result of a genetic mutation - reports New Scientist. You can read about gene therapy, what it is and its prospects, on the website News Medical Life Sciencies

17.01.2024

Source: Memorial Sloan Kettering Cancer Center Library / LibGuides / COVID Impacts / Immune Dysfunction

Detailed information and resources on the long-term health consequences of COVID-19 infection and the broad social impacts of the COVID-19 pandemic.

One of the most concerning long-term effects of COVID-19 is the dysregulation and dysfunction of the immune system.

08.08.2023

Source: Nutrients Authors: van Steenwijk H, Bast, A and de Boer A.

Beta-glucans derived from mushrooms are bioactive long-chain polysaccharide compounds, insoluble in water and with immunomodulatory properties. Knowledge of the action and functions of beta-glucans, which have been used in traditional medicine for centuries, is developing thanks to modern immunological and biotechnological methods.

04.08.2023

Source: Oncology Reports; Authors: Hiromi Okuyama Akira Tominaga, z Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka 584-8540, Japan

Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ